However, our results show that overexpression of CXCR6 and then treatment with CXCL16 for 24 or 48 hours in BC cells didn't alter the apparent expression of E-cadherin epithelial markers and vimentin mesenchymal markers (Supplementary Figure 3). The gene discussed is CXCR6; the disease is breast cancer.